Calc Periop Doac

Last 30 days

Uptime

100%

Response time

149 ms typical, 304 ms slowest 5%

Last check

1 h ago

Next check

any minute now

How to call it

# See the payment challenge (nothing is charged)
curl -i -X POST "https://api.magentlab.com/api/calc/periop_doac" \
  -H "content-type: application/json" \
  -d '{"items":[{"bleed_risk":"low_to_moderate","crcl_ml_min":40,"doac":"apixaban"},{"bleed_risk":"low_to_moderate","crcl_ml_min":40,"doac":"apixaban"}]}'

import { wrapFetchWithPayment } from "@x402/fetch";
import { x402Client } from "@x402/core/client";
import { ExactEvmScheme } from "@x402/evm/exact/client";
import { privateKeyToAccount } from "viem/accounts";

const client = new x402Client().register(
  "eip155:8453",
  new ExactEvmScheme(privateKeyToAccount(process.env.AGENT_KEY)),
);
const pay = wrapFetchWithPayment(fetch, client);

// Not sure it's safe to pay? Preflight it first for $0.005:
// GET https://toolvet.app/api/v1/check?url=https%3A%2F%2Fapi.magentlab.com%2Fapi%2Fcalc%2Fperiop_doac
const res = await pay("https://api.magentlab.com/api/calc/periop_doac", {
  method: "POST",
  headers: { "content-type": "application/json" },
  body: JSON.stringify({"items":[{"bleed_risk":"low_to_moderate","crcl_ml_min":40,"doac":"apixaban"},{"bleed_risk":"low_to_moderate","crcl_ml_min":40,"doac":"apixaban"}]}),
});
console.log(await res.json());

Example input

{
  "items": [
    {
      "bleed_risk": "low_to_moderate",
      "crcl_ml_min": 40,
      "doac": "apixaban"
    },
    {
      "bleed_risk": "low_to_moderate",
      "crcl_ml_min": 40,
      "doac": "apixaban"
    }
  ]
}

Example output

{
  "count": 2,
  "items": [
    {
      "bleed_risk": "low_to_moderate",
      "citation": {
        "authors": "Douketis JD, Spyropoulos AC, Murad MH, et al.",
        "doi": "10.1016/j.chest.2022.07.025",
        "id": "douketis-2022",
        "pmid": "35964704",
        "source": "Chest. 2022;162(5):e207-e243",
        "title": "Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline"
      },
      "criteria": [
        {
          "factor": "doac",
          "met": true,
          "value": "apixaban"
        },
        {
          "factor": "high_bleed_risk",
          "met": false,
          "value": "low_to_moderate"
        },
        {
          "factor": "dabigatran",
          "met": false
        },
        {
          "factor": "dabigatran_crcl_lt_50",
          "met": false
        }
      ],
      "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
      "doac": "apixaban",
      "formula": "periop_doac",
      "formula_expression": "Douketis 2022 PAUSE-style elective DOAC interruption (recommendations 22-25): apixaban/rivaroxaban/edoxaban hold 1 day (low_to_moderate) or 2 days (high); dabigatran CrCl>=50 same 1/2; dabigatran CrCl<50 hold 2 (low_to_moderate) or 4 (high); resume 1 day after low_to_moderate or 2 days after high; heparin_bridge always false (recommendation 26)",
      "heparin_bridge": false,
      "hold_days_before": 1,
      "resume_days_after": 1,
      "total_pre_post_days": 2
    },
    {
      "bleed_risk": "low_to_moderate",
      "citation": {
        "authors": "Douketis JD, Spyropoulos AC, Murad MH, et al.",
        "doi": "10.1016/j.chest.2022.07.025",
        "id": "douketis-2022",
        "pmid": "35964704",
        "source": "Chest. 2022;162(5):e207-e243",
        "title": "Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline"
      },
      "criteria": [
        {
          "factor": "doac",
          "met": true,
          "value": "apixaban"
        },
        {
          "factor": "high_bleed_risk",
          "met": false,
          "value": "low_to_moderate"
        },
        {
          "factor": "dabigatran",
          "met": false
        },
        {
          "factor": "dabigatran_crcl_lt_50",
          "met": false
        }
      ],
      "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
      "doac": "apixaban",
      "formula": "periop_doac",
      "formula_expression": "Douketis 2022 PAUSE-style elective DOAC interruption (recommendations 22-25): apixaban/rivaroxaban/edoxaban hold 1 day (low_to_moderate) or 2 days (high); dabigatran CrCl>=50 same 1/2; dabigatran 

Security scan

• No findings. We scan names, descriptions and tool definitions for hidden instructions and other prompt-injection patterns.

Recent checks